Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in VIR BIOTECHNOLOGY INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 121,080 shares of VIR (VIR BIOTECHNOLOGY INC), worth $730,113 as of 2025-Q4. The position was decreased (-15.9% shares). VIR represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$730,113
Current Shares
121,080
Total Value Change
-$787,862
Total Shares Change
-49,479
Other major holders of VIR: CAPITAL FUND MANAGEMENT S.A.
Decreased |
| 121,080 |
-15.9% |
| $730,113 |
| 0.0% |
| $5.84 |
0 |
| 2025-Q3 | Decreased | 143,938 | -51.1% | $821,886 | 0.0% | $5.63 | 0 |
| 2025-Q2 | Increased | 294,383 | +47.9% | $1.5M | 0.0% | $5.17 | 35 |
| 2025-Q1 | Increased | 199,063 | +9.8% | $1.3M | 0.0% | $6.70 | 28 |
| 2024-Q4 | Increased | 181,325 | +29.2% | $1.3M | 0.0% | $7.33 | 32 |
| 2024-Q3 | Decreased | 140,371 | -17.7% | $1.1M | 0.0% | $7.53 | 0 |
| 2024-Q2 | Increased | 170,559 | +85.3% | $1.5M | 0.0% | $8.90 | 40 |